Result of General Meeting and Update on Strategic Review
Bellevue Healthcare Trust plc (the "Company") is pleased to announce that the special resolution put forward at its General Meeting held earlier today was passed, authorising the Company to make purchases of its own shares in order to support the continued operation of the Zero Discount Policy.
The text of the resolution is continued in the shareholder circular (the "Circular"), which is available on the Company's website at www.bellevuehealthcaretrust.com
The proxy votes received were as follows:
| Special resolution | In Favour / Discretionary | Against | Withheld | ||
| 1.To give authority for the Company to purchase its own shares | 20,473,175 | 93.83% | 1,345,568 | 6.17% | 15,116 |
At the time of the above meeting, the Company's issued ordinary share capital consisted of 315,152,309 Ordinary Shares, of which 224,478,871 Ordinary shares were held in Treasury. Therefore, the total number of voting rights in the Company was 90,673,438. Each Ordinary Share held entitles the holder to one vote and there are no restrictions on those voting rights. A "Vote withheld" is not a vote in law and is not counted in the calculation of the % of shares voted "For" or "Against" a resolution.
Copies of the resolution passed will be submitted to the National Storage Mechanism and will shortly be available for inspection at: https://data.fca.org.uk/#/nsm/nationalstoragemechanism
Update on Strategic Review
Further to the announcement of the results of the Company's strategic review and the Board's intention to appoint Columbia Threadneedle Investments as the Company's investment manager, the Board is continuing to make progress on the detailed proposals to be put to shareholders for approval, and is consulting with current and prospective new investors in the Company. The Board now expects to publish a circular with full details of the proposals, including a notice convening a general meeting, in the early part of next year.
8 December 2025
Enquiries
NSM Funds (UK) Limited
Company Secretary
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
